New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

Advertisement
Advertisement
StocksVTRS

ETFs with exposure to Viatris, Inc. (VTRS)

496 ETFs hold Viatris, Inc. (VTRS)
Holdings data as of May 31, 2026
Davis Select U.S. Equity ETF - USD
This ETF provides exposure to Other Large Cap US Equities
5.68%
+2.34%
+11.11%
+€19M
+€146M
€1.08B
0.59%
Not rated
iShares U.S. Pharmaceuticals ETF - USD
This ETF provides exposure to US Pharmaceuticals Equities
5.00%
+9.19%
+16.62%
+€134M
+€128M
€997M
0.38%
Davis Select Worldwide ETF - USD
This ETF provides exposure to Other Global Equities
4.43%
-3.41%
+0.45%
+€917K
+€47M
€506M
0.62%
Not rated
Adaptiv Select ETF - USD
This ETF provides exposure to Large Cap US Equities
4.23%
+0.77%
+9.79%
+€1.6M
+€9.5M
€164M
1%
Not rated
First Trust Nasdaq Pharmaceuticals ETF - USD
This ETF provides exposure to Other US Pharmaceuticals Equities
4.00%
+11.40%
+16.63%
-€1.5M
+€8.9M
€32M
0.6%
Leatherback Long/Short Alternative Yield ETF - USD
This ETF provides exposure to US Equities
3.70%
-0.17%
+4.90%
€0
-€4.6M
€15M
1.2%
Not rated
Miller Value Partners Appreciation ETF - USD
This ETF provides exposure to Other Equities
2.84%
+1.73%
+1.79%
-€36K
-€1.7K
€59M
0.6%
Not rated
Invesco Dynamic Pharmaceuticals ETF - USD
This ETF provides exposure to Equally Weighted US Pharmaceuticals Equities
2.80%
+9.54%
+13.11%
-€9.9M
-€204K
€311M
0.57%
Cambria Large Cap Shareholder Yield ETF - USD
This ETF provides exposure to Equally Weighted Large Cap US Equities
2.31%
+0.39%
+9.04%
+€662K
+€660K
€5.9M
0.59%
Not rated
AAM S&P 500 High Dividend Value ETF - Distributing - USD
This ETF provides exposure to Equally Weighted Large Cap US Equities
2.28%
-1.00%
+13.25%
+€2.5M
+€8.2M
€84M
0.29%
See more results with a Trackinsight account
Get started with a free Essentials account today.
Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight